Biogen (BIIB) EBT Margin (2009 - 2026)

Biogen's EBT Margin history runs 18 years deep, the most recent figure standing at 15.24% for Q1 2026.

• In Q1 2026, EBT Margin rose 244.0% year-over-year to 15.24%; the TTM figure through Mar 2026 stood at 16.33% (down 152.0% YoY), while the FY2025 annual figure was 15.74%, down 396.0% from the prior year.
• EBT Margin was 15.24% for Q1 2026 at Biogen, up from 2.46% in the prior quarter.
• In the past five years, EBT Margin ranged from a high of 54.66% in Q3 2022 to a low of 5.58% in Q3 2023.
• Historically, EBT Margin has averaged 20.52% across 5 years, with a median of 18.29% in 2024.
• The sharpest annual moves came in 2022 and 2023: EBT Margin jumped 4418 bps in 2022, then slumped 6024 bps in 2023.
• A 5-year view of EBT Margin shows it stood at 23.73% in 2022, then plunged by 49 bps to 12.22% in 2023, then dropped by 3 bps to 11.88% in 2024, then slumped by 121 bps to 2.46% in 2025, then soared by 720 bps to 15.24% in 2026.
• The last three EBT Margin figures came in at 15.24% (Q1 2026), 2.46% (Q4 2025), and 21.99% (Q3 2025), per Business Quant data.